C09972005 / invoice 10000
Species:CANINE
Breed:Poodle - Toy Cross
Age (years):6
Diagnosis or signs:Skin condition
Consult notes
HISTORYPresenting for: Murphy presented for ongoing pruritus and secondary skin infections, with continued itching despite previous cytopoint 2 months agoHistorical Conditions: Previous Malassezia infection on feet treated, ears were fairly clean at last visit, received Cytopoint injection 2 months ago (10mg) at same time as vaccinesSkin: Ongoing pruritus affecting feet and other areas of body, licking and chewing at feet, previous crusty discharge between toesCurrent Meds: Cortavance (bottle with syringes for ears), Malaseb washes for feet every 2nd day, cytopoint last 2 months agoEXAMBehavioural: Nervous during examination, watching veterinarian closelyEars: Clean bilaterally, no discharge or inflammation notedIntegumentary: Feet looking significantly improved compared to previous visit, minimal crusty discharge between digits, no significant erythema or swelling noted between toesDiagnostics: Cytology from feet - very few Malassezia organisms present, some bacteria consistent with normal flora, no overgrowth of concern. Secondary infections appear under controlear cytology: AWNLASSESSMENTAllergic dermatitis with secondary Malassezia infection - secondary infections now under control but underlying pruritus persists, likely requiring ongoing allergy management. Cytopoint effects have worn off after 2 monthsPLANNew Meds/Tx:- Cytopoint injection administered today for allergy control- Cortavance spray can be used on feet 1-2 sprays per foot once daily if needed for localised inflammation and itchingAdditional Discussion:- Malaseb foot washes can be reduced in frequency as Malassezia infection is now controlled- If current Cytopoint dose insufficient, can consider increasing dose or alternative daily oral allergy medications- Monitor for recurrence of crusty discharge between toes, resume more frequent washing if needed- Continue current ear treatment protocol as ears remain clean
Animal clinical history (3 most recent)
2026-03-02T00:00:00Z 10:00?am
HISTORYPresenting for: Murphy presented for ongoing pruritus and secondary skin infections, with continued itching despite previous cytopoint 2 months agoHistorical Conditions: Previous Malassezia infection on feet treated, ears were fairly clean at last visit, received Cytopoint injection 2 months ago (10mg) at same time as vaccinesSkin: Ongoing pruritus affecting feet and other areas of body, licking and chewing at feet, previous crusty discharge between toesCurrent Meds: Cortavance (bottle with syringes for ears), Malaseb washes for feet every 2nd day, cytopoint last 2 months agoEXAMBehavioural: Nervous during examination, watching veterinarian closelyEars: Clean bilaterally, no discharge or inflammation notedIntegumentary: Feet looking significantly improved compared to previous visit, minimal crusty discharge between digits, no significant erythema or swelling noted between toesDiagnostics: Cytology from feet - very few Malassezia organisms present, some bacteria consistent with normal flora, no overgrowth of concern. Secondary infections appear under controlear cytology: AWNLASSESSMENTAllergic dermatitis with secondary Malassezia infection - secondary infections now under control but underlying pruritus persists, likely requiring ongoing allergy management. Cytopoint effects have worn off after 2 monthsPLANNew Meds/Tx:- Cytopoint injection administered today for allergy control- Cortavance spray can be used on feet 1-2 sprays per foot once daily if needed for localised inflammation and itchingAdditional Discussion:- Malaseb foot washes can be reduced in frequency as Malassezia infection is now controlled- If current Cytopoint dose insufficient, can consider increasing dose or alternative daily oral allergy medications- Monitor for recurrence of crusty discharge between toes, resume more frequent washing if needed- Continue current ear treatment protocol as ears remain clean Vital Signs Weight: 9.3;
Previous claim history (18)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-02-19 | C09925216 | HYPERSENSITIVITY (ALLERGIC) SKIN DISORDER |
| 2026-01-12 | C09744247 | HYPERSENSITIVITY (ALLERGIC) SKIN DISORDER |
| 2025-12-20 | C09655029 | OTITIS EXTERNA |
| 2025-12-11 | C09610057 | OTITIS EXTERNA |
| 2024-03-05 | C6956648 | LAMENESS LF |
| 2024-02-21 | C6905149 | LAMENESS LF |
| 2024-01-12 | C6749772 | HEARTWORM CONTROL |
| 2024-01-12 | C6749772 | VACCINATIONS OR HEALTH CHECKS |
| 2023-11-07 | C6507347 | HYPERSENSITIVITY (ALLERGIC) SKIN DISORDER |
| 2023-11-07 | C6507347 | INAPPETANCE |
| 2023-04-24 | C5828055 | COUGHING - PRESENTING COMPLAINT |
| 2023-04-18 | C5805137 | ATOPY |
| 2022-11-25 | C5472186 | ATOPY |
| 2022-11-02 | C5251236 | ANAL SAC ABSCESS |
| 2022-10-28 | C5244622 | ANAL SAC ABSCESS |
| 2022-08-04 | C4985177 | MISCELLANEOUS CONDITIONS |
| 2021-12-31 | C4360534 | HEARTWORM CONTROL |
| 2021-12-31 | C4360534 | VACCINATIONS OR HEALTH CHECKS |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_consultation-revisit | 72.00 | 2026-03-02 | — |
| 20000 | tstarc_skin_medication_-_cytopoint | 172.30 | 2026-03-02 | — |
| 30000 | tstarc_diagnostic_test_-_cytology | 70.40 | 2026-03-02 | — |
UPM+
- DG02339HYPERSENSITIVITY DISORDER (ALLERGY)DSTP_skin_-_allergic_disorder
Variant (sleepy_king)
HYPERSENSITIVITY DISORDER (ALLERGY)
DSTP_skin_-_allergic_disorder
Conf: 0.760
Threshold: 0.38
Above: ✓
Correct?